PACAP-27 vs Insulin Lispro

Head-to-head comparison of PACAP-27 (Pituitary Adenylate Cyclase-Activating Polypeptide-27) and Insulin Lispro (Insulin lispro (B28-Lys, B29-Pro human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyPACAP-27Insulin Lispro
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NamePituitary Adenylate Cyclase-Activating Polypeptide-27Insulin lispro (B28-Lys, B29-Pro human insulin analog)
Molecular Weight3158 Da5808.0 Da
Half-LifeminutesAbout 1 hour
Amino Acids2751
Typical DoseResearch-only: 0.1-1 nmol/kg0.05-0.2 U/kg per meal
RouteIntraperitoneal/SubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count22012000
Research StatusPre-clinicalApproved

PACAP-27 Benefits

  • anti-apoptotic signaling
  • insulin secretagogue effect
  • reduced ER stress
  • islet cytoprotection

Insulin Lispro Benefits

  • Rapid postprandial glucose control
  • Flexible premeal timing
  • Predictable onset of action
  • Useful in basal-bolus regimens

PACAP-27 Dosing

0.1-1 nmol/kg in animal studies|10-100 nM in vitro|research-only intermittent dosing

Insulin Lispro Dosing

Inject SC 0-15 minutes before meals|Adjust dose to carbohydrate intake and premeal glucose|Often paired with a basal insulin

PACAP-27 Side Effects

  • flushing
  • hypotension at high exposure
  • headache

Insulin Lispro Side Effects

  • Hypoglycemia
  • Weight gain
  • Injection-site reactions

Research Overview

PACAP-27

PACAP-27 has been repeatedly shown to support beta-cell survival through cAMP/PKA and related pathways. In experimental models it mitigates cytokine damage, preserves insulin content, and helps maintain islet viability.

Insulin Lispro

Clinical studies show faster onset and shorter duration than regular insulin, improving post-meal glucose control. It is a standard comparator in diabetes pharmacology and closed-loop insulin-delivery research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

PACAP-27 stacks with:

GLP-1 analogsDPP-4 inhibitorsdiet and exercise

Insulin Lispro stacks with:

Insulin GlargineInsulin Degludec
neuropeptidebeta-cell protectioncAMP signalingrapid-acting insulinprandial controlglucose regulation